Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry
…, R Asselta, J Ruiz‐Martinez, E Mondragón… - Movement …, 2017 - Wiley Online Library
Background Penetrance estimates of the leucine‐rich repeat kinase 2 (LRRK2) p.G2019S
mutation for PD vary widely (24%‐100%). The p.G2019S penetrance in individuals of …
mutation for PD vary widely (24%‐100%). The p.G2019S penetrance in individuals of …
[HTML][HTML] Prognostic biomarkers of Parkinson's disease in the Spanish EPIC cohort: A multiplatform metabolomics approach
…, E Ardanaz, M Konjevod, E Mondragon… - npj Parkinson's …, 2021 - nature.com
The lack of knowledge about the onset and progression of Parkinson’s disease (PD)
hampers its early diagnosis and treatment. Metabolomics might shed light on the PD imprint …
hampers its early diagnosis and treatment. Metabolomics might shed light on the PD imprint …
The genetic architecture of Parkinson disease in Spain: characterizing population‐specific risk, differential haplotype structures, and providing etiologic insight
…, A Gorostidi, JA Bergareche, E Mondragon… - Movement …, 2019 - Wiley Online Library
Background The Iberian Peninsula stands out as having variable levels of population admixture
and isolation, making Spain an interesting setting for studying the genetic architecture of …
and isolation, making Spain an interesting setting for studying the genetic architecture of …
The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies
…, F Lomeña, C Marras, E Mondragon… - Movement …, 2017 - Wiley Online Library
Background: Asymptomatic, nonmanifesting carriers of leucine‐rich repeat kinase 2
mutations are at increased risk of developing PD. Clinical and neuroimaging features may be …
mutations are at increased risk of developing PD. Clinical and neuroimaging features may be …
Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia
…, A Bergareche, I Albajar, E Mondragón… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Dominantly inherited GAA repeat expansions in the fibroblast growth
factor 14 (FGF14) gene have recently been shown to cause spinocerebellar ataxia 27B (…
factor 14 (FGF14) gene have recently been shown to cause spinocerebellar ataxia 27B (…
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
…, J Ruiz‐Martinez, E Mondragon… - Movement …, 2019 - Wiley Online Library
Background Increased cancer risk has been reported in Parkinson's disease (PD) patients
carrying the leucine rich repeat kinase 2 (LRRK2) G2019S mutation (LRRK2‐PD) in …
carrying the leucine rich repeat kinase 2 (LRRK2) G2019S mutation (LRRK2‐PD) in …
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease
…, J Ruiz‐Martínez, E Mondragón… - Movement …, 2016 - Wiley Online Library
Background The objective of this study was to study motor and nonmotor symptoms and
striatal dopaminergic denervation, as well as the relationship between them, in a cohort of …
striatal dopaminergic denervation, as well as the relationship between them, in a cohort of …
Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance
…, JR Martinez, E Mondragon Rezola… - Movement …, 2020 - Wiley Online Library
Background The penetrance of leucine rich repeat kinase 2 (LRRK2) mutations is incomplete
and may be influenced by environmental and/or other genetic factors. Nonsteroidal anti‐…
and may be influenced by environmental and/or other genetic factors. Nonsteroidal anti‐…
[HTML][HTML] R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
…, A Bergareche-Yarza, E Mondragón-Rezola… - Acta …, 2021 - Springer
Heterozygous gain-of-kinase function variants in LRRK2 (leucine-rich repeat kinase 2)
cause 1–2% of all cases of Parkinson’s disease (PD) albeit with incomplete and age-dependent …
cause 1–2% of all cases of Parkinson’s disease (PD) albeit with incomplete and age-dependent …
Diagnosis of genetic white matter disorders by singleton whole-exome and genome sequencing using interactome-driven prioritization
…, J Armstrong, I Marti, E Mondragón Rezola… - Neurology, 2022 - AAN Enterprises
Background and Objectives Genetic white matter disorders (GWMD) are of heterogeneous
origin, with >100 causal genes identified to date. Classic targeted approaches achieve a …
origin, with >100 causal genes identified to date. Classic targeted approaches achieve a …